Thermo Fisher ( NYSE: TMO) is nearing a takeover of Clario in an all-cash deal that could value the clinical trial data ...

Key drivers of this growth include the increasing number of decentralized clinical trials, the rising adoption ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

Key opportunities in the clinical trial platform market include leveraging AI and machine learning for enhanced trial design ...

"With our new AI-native clinical encounter, we're ushering in a new era where technology fades into the background. It listens to the visit, understands the context, and engages in real time - so ...

Altamont Software, a provider of enterprise medical connectivity solutions, announces the availability of our Dynamic Content engine within Passport SR. This feature provides the ability to calculate ...

Copenhagen, Denmark, November 4, 2025, (GLOBE NEWSWIRE) – BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR), today announced an update on its ongoing adult clinical study in the US.

Mechelen, Belgium; November 3, 2025, 22:01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it will present new and updated data for CAR T-cell therapy candidate, GLPG51011, at the ...

Beta Bionics, Inc. (($BBNX)) announced an update on their ongoing clinical study. Beta Bionics, Inc. has initiated a clinical study titled ‘iLet ...

Thermo Fisher said on Wednesday it would buy privately held data management company Clario for up to $9.4 billion in cash and ...

One analysis showed participant costs were substantially lower – 8% below an employer client's general adult population and ...

The healthcare industry is experiencing a fundamental transformation — a shift from the traditional fee-for-service model to ...